<DOC>
	<DOCNO>NCT00249574</DOCNO>
	<brief_summary>The purpose study see whether street-recruited heroin user successfully treat hepatitis C stabilize buprenorphine .</brief_summary>
	<brief_title>Bridging Active Heroin Users Hepatitis C Treatment Using Buprenorphine - 1</brief_title>
	<detailed_description>This prospective pilot safety study base hypothesis active , street-recruited heroin user successfully treat hepatitis C stabilization buprenorphine . Eligible subject actively use heroin hepatitis C viremia ; screen occur street-based site like syringe exchange program . Those eligible sign inform consent , ask attend 3 weekly educational session hepatitis C addiction well undergo intake interview . After , subject induct onto buprenorphine/naloxone combination therapy ( Suboxone ) receive medication 12-24 week . Once reach 12-24 week study time point , subject option 12-week Suboxone taper , instead undergo 6-12 month hepatitis C treatment pegylated interferon ribavirin maintain Suboxone . Once complete hepatitis C treatment , subject undergo 24-week Suboxone taper , transition outpatient Suboxone therapy medical provider .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Active heroin illicit opioid use Active hepatitis C No medical psychiatric contraindication Able sign inform consent No opiate dependence Age &lt; 18 Unable uninterested attend weekly group session</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>heroin addiction</keyword>
</DOC>